Evidence map›Paper›PMID 34573160›Full record

ArticleBrain sciences2021

Clinical Spectrum and Neuroimagistic Features in Hospitalized Patients with Neurological Disorders and Concomitant Coronavirus-19 Infection.

Anca Elena Gogu, Andrei Gheorghe Motoc, Alina Zorina Stroe, Any Docu Axelerad, Daniel Docu Axelerad, Florina Pârv, Georgiana Munteanu, Flavius Dan, Dragos Catalin Jianu

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Anca Elena GoguDepartment of Neurology, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania.
Andrei Gheorghe MotocCentre for Cognitive Research in Neuropsychiatric Pathology (NeuroPsy-Cog), "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania.
Alina Zorina StroeDepartment of Neurology, General Medicine Faculty, "Ovidius" University, 900470 Constanta, Romania.
Any Docu AxeleradDepartment of Neurology, General Medicine Faculty, "Ovidius" University, 900470 Constanta, Romania.
Daniel Docu AxeleradBrainaxy Clinic, 900628 Constanta, Romania.
Florina PârvDepartment of Cardiology, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania.
Georgiana MunteanuDepartment of Neurology, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania.
Flavius DanDepartment of Neurology, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania.ORCID 0000-0002-4146-7681
Dragos Catalin JianuDepartment of Neurology, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania.ORCID 0000-0002-7827-818X
Victor Babeș University of Medicine and Pharmacy Timișoara · ROOvidius University · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the first months of the COVID-19 pandemic, several research studies focused on understanding the damage to the respiratory and circulatory systems. However, the evidence of neurological manifestations as part of the clinical spectrum of the disease has increased. The aim of this retrospective study was to determine the potential association of neurological disorders with concomitant COVID-19 infection. We reviewed 101 patients (mean age, 70.05 years; 62.37% men) diagnosed with different neurological disorders and COVID-19 who were referred to the Department of Neurology between March 2020 and May 2021. The protocol included demographic, clinical, and neuroimagistic features, biochemical evaluation data, and prognosis. In the first group of patients with non-severe COVID-19 infection (<50% lung damage), we enrolled 75 cases (mean age, 69.13 years; 65.33% men), and the second group, with 26 patients (mean age, 72.69 years; 53.84% men), developed severe COVID-19 infection (>50% lung damage). Severe COVID-19 infection was significantly correlated with an increased highly sensitive C-reactive protein level (hsCRP) (

Indexed as

COVID-19 infectionneurological disordersstroke

Identifiers

PMID34573160
PMCPMC8466125
OpenAlexW3197720336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.